INS and Hepatic steatosis: Future research should focus on identifying strategies to enhance adherence to the MD in the pediatric population, as increasing evidence suggests that, even without weight loss, the MD reduces liver steatosis and improves insulin sensitivity in insulin-resistant adults with MASLD [82].